HEX

File: /home/robovet/mail/new/1647661356.M672271P3302667.host40.registrar-servers.com,S=4605,W=4706
Envelope-to: [email protected]
Delivery-date: Fri, 18 Mar 2022 23:42:36 -0400
Auto-Submitted: auto-replied
From: Mail Delivery System <[email protected]>
To: [email protected]
References: <[email protected]>
Content-Type: multipart/report; report-type=delivery-status; boundary=1647661356-eximdsn-314319987
MIME-Version: 1.0
Subject: Mail delivery failed: returning message to sender
Message-Id: <[email protected]>
Date: Fri, 18 Mar 2022 23:42:36 -0400

--1647661356-eximdsn-314319987
Content-type: text/plain; charset=us-ascii

This message was created automatically by mail delivery software.

A message that you sent could not be delivered to one or more of its
recipients. This is a permanent error. The following address(es) failed:

  [email protected]
    No Such User Here

--1647661356-eximdsn-314319987
Content-type: message/delivery-status

Reporting-MTA: dns; host40.registrar-servers.com

Action: failed
Final-Recipient: rfc822;[email protected]
Status: 5.0.0

--1647661356-eximdsn-314319987
Content-type: message/rfc822

Return-path: <[email protected]>
Received: from robovet by host40.registrar-servers.com with local (Exim 4.94.2)
	(envelope-from <[email protected]>)
	id 1nVPzA-00Dsmq-F0
	for [email protected]; Fri, 18 Mar 2022 23:42:36 -0400
To: [email protected]
Subject: =?us-ascii?Q?Robovet__"a_treatment_for_cytomegalovirus_(cmv)?=  =?us-ascii?Q?_retinitis_in_people_with_aids."?=
X-PHP-Script: www.robovet.com/index.php for 207.244.232.161, 207.244.232.161
X-PHP-Filename: /home/robovet/public_html/index.php REMOTE_ADDR: 207.244.232.161
Date: Sat, 19 Mar 2022 03:42:36 +0000
From: Robovet <[email protected]>
Reply-To: [email protected]
Message-ID: <[email protected]>
X-Mailer: PHPMailer 6.5.0 (https://github.com/PHPMailer/PHPMailer)
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable
Sender:  <[email protected]>

From: tcsgroupa <[email protected]>=0ASubject: a treatment for cytomegalovir=
us (cmv) retinitis in people with aids.=0A=0AMessage Body:=0A<a href=3Dhttp=
s://www.tcspharma.net/pro/Cidofovir_113852-37-2_for_cream_usage_injection_s=
tructure_and_price.html>cidofovir</a>, brand name vistide, is an injectable=
 antiviral medication primarily used as a treatment for cytomegalovirus (cm=
v) retinitis (an infection of the retina of the eye) in people with aids.=
=20
=20
cidofovir was approved for medical use in 1996.=20
=20
medical use=20
dna virus=20
its only indication that has received regulatory approval worldwide is cyto=
megalovirus retinitis. cidofovir has also shown efficacy in the treatment o=
f aciclovir-resistant hsv infections. cidofovir has also been investigated =
as a treatment for progressive multifocal leukoencephalopathy with successf=
ul case reports of its use. despite this, the drug failed to demonstrate an=
y efficacy in controlled studies. cidofovir might have anti-smallpox effica=
cy and might be used on a limited basis in the event of a bioterror inciden=
t involving smallpox cases. brincidofovir, a cidofovir derivative with much=
 higher activity against smallpox that can be taken orally has been develop=
ed. it has inhibitory effects on varicella-zoster virus replication in vitr=
o although no clinical trials have been done to date, likely due to the abu=
ndance of safer alternatives such as aciclovir. cidofovir shows anti-bk vir=
us activity in a subgroup of transplant recipients. cidofovir is being inve=
stigated as a complementary intralesional therapy against papillomatosis ca=
used by hpv.=20
=20
it first received fda approval on 26 june 1996, tga approval on 30 april 19=
98 and ema approval on 23 april 1997.=20
=20
it has been used topically to treat warts.=0A=0A-- =0AThis e-mail was sent =
from a contact form on Robovet  (http://www.robovet.com)

--1647661356-eximdsn-314319987--